Phase
Condition
Enuresis
Urinary Incontinence
Nocturia
Treatment
Sulbutiamine
Imipramine
Clinical Study ID
Ages 6-18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age : 6 - 18 years old.
All children diagnosed by Primary monosymptomatic nocturnal enuresis in this agegroup.
Exclusion
Exclusion Criteria:
Secondary nocturnal enuresis (child who has been continent for at least 6 monthsbefore the onset of bedwetting ).
congenital anomalies (Posterior urethral valve , ectopic ureter , ectopia vesica ,...)
history of previous lower urinary tract surgery (Multiple hypospadias surgeries ,..., )
neurogenic bladder (as underactive bladder ).and urge incontinence.
presence of post-void residual urine greater than 20% of functional bladdercapacity.
history or evidence of disorders in other organs such as (cardiovascular systemdisease), liver , psychological problems , evident allergic reaction to bothmedication.
Study Design
Connect with a study center
Sohag Faculty of Medecine
Sohag,
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.